SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-072173
Filing Date
2018-03-06
Accepted
2018-03-06 16:36:03
Documents
5
Period of Report
2018-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d522906d8k.htm 8-K 20843
2 EX-99.1 d522906dex991.htm EX-99.1 20630
3 EX-99.2 d522906dex992.htm EX-99.2 10935
4 EX-99.3 d522906dex993.htm EX-99.3 9555
5 GRAPHIC g522906g0305195314872.jpg GRAPHIC 3603
  Complete submission text file 0001193125-18-072173.txt   68269
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 18670369
SIC: 2834 Pharmaceutical Preparations